Stay updated on Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study record for the RESOLVE phase 3 trial of ibrutinib with chemotherapy versus placebo is displayed, including its design, eligibility criteria, participating locations, and outcome measures.
    Difference
    88%
    Check dated 2026-11-10T18:40:44.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now shows revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-03T18:55:41.000Z thumbnail image
  3. Check
    24 days ago
    Change Detected
    Summary
    An NIH-wide banner announces a website terminology transition involving “Super Intelligence” and “Artificial Intelligence.” The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:19:58.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T19:40:35.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Access to the study record content is blocked by a 403 Forbidden error, replacing the detailed study information and documents with a generic error screen. This change means users cannot view the study details, documents, or related navigation on this page.
    Difference
    18%
    Check dated 2026-09-22T22:18:42.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.6 to v3.7.0, indicating an underlying CMS update.
    Difference
    0.0%
    Check dated 2026-09-15T20:42:44.000Z thumbnail image

Stay in the know with updates to Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page.